tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Halozyme raises FY24 non-GAAP EPS view to $3.65-$4.05 from $3.55-$3.90

Consensus for FY24 EPS is $3.73. Raises FY24 revenue view to $935M-$1.02B from $915M-$985M, consensus $947.33M.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1